Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1991 Dec;26(12):1257-63.
doi: 10.1007/BF02536543.

Platelet-activating factor in cardiovascular stress situations

Affiliations
Review

Platelet-activating factor in cardiovascular stress situations

R Rabinovici et al. Lipids. 1991 Dec.

Abstract

Since the elucidation of its chemical structure two decades ago, platelet-activating factor (PAF) has emerged as an important mediator of various cardiovascular stress situations. Most notably, PAF was implicated as a key factor in the septic shock syndrome, based on the similarities between endotoxin and PAF biological effects, the elevation of circulating and tissue levels of PAF during endotoxemia, and the protective effect of PAF antagonists in the septic state. In addition, accumulating data suggest the involvement of PAF in the pathophysiological processes associated with ischemia, hemorrhage and trauma, where PAF exerts its effects directly on cells and blood elements or indirectly through interactions with other mediators such as cytokines and prostaglandins. Nevertheless, the relative contribution of PAF to the pathophysiological processes in endotoxemia is still unknown and should await further investigations. The primary aims of this chapter are: to delineate the effects of PAF on the cardiovascular system, to summarize the data which suggest the involvement of PAF in stress situations of the cardiovascular system, and to identify areas where future experimental efforts should be focused.

PubMed Disclaimer

Similar articles

References

    1. J Clin Invest. 1984 Oct;74(4):1193-203 - PubMed
    1. Blood. 1988 Mar;71(3):672-6 - PubMed
    1. Hypertension. 1986 Sep;8(9):737-41 - PubMed
    1. Br J Pharmacol. 1983 Sep;80(1):81-3 - PubMed
    1. Kidney Int. 1986 Feb;29(2):469-77 - PubMed

MeSH terms

Substances

LinkOut - more resources